Racing To Invest? The Dynamics of Competition in Ethical Drug Discovery (original) (raw)

Abstract

Recent advances in the theoretical literature have greatly expanded our understanding of the forces that shape the competitive dynamics of research and development, but a paucity of suffzciently detailed empirical data has left these insights relatively untested. W e draw on unusually detailed qualitative and quantitative infernal data provided at the research program level by 10 major pharmaceutical firms to explore the usefulness of the modern literature as a source of insight into the dynamics of competition in ethical drug discovery.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (45)

  1. Anderson, T.W. and C. IIsiao, 1Y82, "Formulation and Estimation of Dynamic Models Using Panel Data," Iournal of Econometrics, 18, 47-88.
  2. Arrow, K., 1962, "Economic Welfare and the Allocation of Resources for Invention," in R. Nelson, ed., The Rate and Direction of Inventive Activity, Princeton, NJ: Princeton University Press, pp. 609-619.
  3. Baldwin, W.L and J.T. Scott, 1987, Market Structure and Tedznological Change, Chur, Switzerland: Harwood Academic Publishers.
  4. Ekrndt, Ernst, 1993, "Price Indexes for Antihypertensive Drugs That Incorporate Qual- ity Change; A Progress Report on a Feasibility Study." MIT Program on the Pharma- ceutical Industry, Working Paper Number 6-92.
  5. Dasgupta, P. and E. Maskin, 1987, "The Simple Economics of Research Portfolios," Economic Journal, 97, 581-595.
  6. -and J. Stiglitz, 1980a, "Industrial Structure and the Nature of Innovative Activity," Economic Journal, 90, 266-293.
  7. -and -, 1980b, "Uncertainty, industry structure and the speed of R&D," Bell Journal, 11, 1-28.
  8. D'Aspremont, C. and A. Jacquemin, 1988, "Cooperative and Noncooperative R&D in Duopoly with Spillovers," American Economic Review, 78, 1133-1137.
  9. -- and --, 1990, "Cooperative and Noncooperative R&D in Duopoly with Spill- overs: Erratum," American Economic Review, 80, 641-642.
  10. DiMasi, J. et al., 1991, "The Cost of Innovation in the Pharmaceutical Industry,"Journal of Health Economics, 10, 107-142.
  11. Dixit, Avinash, 1988, "A General iMode1 of R&D Competition and Policy," Rand Journal of Economics, 19, 317-326.
  12. Fraja, Giovanni, 1993, "Strategic Spillovers in Patent Races," International Journal of Industrial Organization, 11, 139-146.
  13. Grabowski, Henry and Nevine Baxter, 1973, "Rivalry in Industrial Research and Devel- opment," Journal of Industrial Economics, 21, 209-235.
  14. Harris, C. and J. Vickers, 1987, "Racing with Uncertainty," Review of Economic Studies, LIV, 1-22.
  15. Henderson, Rebecca, and iain Cockburn, 1993, "Scale, Scope, and Spillovers: Determi- nants of Research Productivity in Ethical Drug Discovery," NBER Working Paper #4476
  16. Khanna, Tarun, 1993, "Racing Behavior: Technological Evolution in the High-End Com- puter Industry." Mimeo, Harvard Business School.
  17. Lee, T.K. and L.L. Wilde, 1980, "Market Structure and Innovation: A Reformulation," Quarterly Journal of Economics, 94, 429-436.
  18. Lerner, Joshua, 1991, "The Empirical Fxploration of a Technology Race: The Winchester Disk Drive Industry, 1972-1988." Mimeo, Harvard Business School.
  19. Levin, Richard C. and Peter C. Reiss, 1988, "Cost-reducing and Demand-creating R&D with Spillovers," Rand Journal of Economics, 19, 538-556.
  20. Loury, Glenn, 1979, "Market Structure and Innovation," Quarterly Journal of Economics, Meron, Amos and Richard E. Caves, 1997, "Rivalry among Firms in Research and Development Outlays," Paper presented at the 1991 UBC Summer I 0 Conference.
  21. Reinganum, J.F., 1982, "A Dynamic Game of R and D: Patent Protection and Competi- tive Behavior," Econometrica, 50, 671-688.
  22. -, 1989, "The Timing of Innovation: Research, Development and Diffusion," in
  23. Schmalensee, R. and R. Willig (eds.), Handbook of Industrial Organization, Volume 1, Amsterdam: North Holland, 1989.
  24. Scherer, F.M., 1967, "Research and Development Resource Allocation Under Rivalry," Quarterly Journal of Economics, 81, 359-394.
  25. ---, 1992, International High Technology Competition, Cambridge, MA: Harvard Univer- sity Press.
  26. Schumpeter, J.A., 1934, The Theory of Economic Development, Cambridge, MA: Harvard University Press.
  27. --, 1950, Capitalism, Socialism and Democracy, Cambridge, MA: Harvard University Press.
  28. Spence, Michael, 1984, "Cost Reduction, Competition and Industry Performance," Econometrica, 52, 101-121. 93, 395-410.
  29. Suslow, Valerie, 1992, "Are There Better Ways to Spell Rehef A Hedonic Pricing Analy- Suzumura, K., 1992, "Cooperative and Noncooperative R&D in an Oligopoly with sis of Ulcer Drugs," University of Michigan, Working Paper #696. Spillovers," American Economic Review, 82, 1307-1320.
  30. S C I E N T I F I C R E F E R E N C E S
  31. Biihler, F.R., J.H. Laragh, L. Baer, E.D. Vaughan Jr., and H.R. Brunner, 1972, "Pro- pranolol Inhbition of Renin Secretion. A Specific Approach to Diagnosis and Treat- ment of Renin-dependent Hypertensive Diseases," New England Journal of Medicine, Brunner, H.R., H. Gavras, J.H. Laragh, J.E. Sealey, 1. Gavras, and R.A. Vukovitch, 1974, "Hypertension in Man. Exposure of the Renin and Sodium Components Using Angiotensin I1 Blockade," Circulation Research (Suppl. l), 34-43.
  32. Case, D.B et al., 1976, "Estimating Renin Participation in Hypertension. Superiority of Converting Enzyme Inhibitor over Saralasin," American Journal of Medicine, 1976, -, 1977, "Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme," New England Journal of Medicine, Cushman, D. W., H.S. Cheung, E.F. Sabo, and M.A. Ondetti, 1977, "Design of Potent Competitive Inhibitors of Angiotensin-Converting Enzyme. Carboxyalkanoyl and Mercaptoalkanoyl Amino Acids, Biochemisty, 16, 5484-5491.
  33. Erdos, E.G. (ed.), 1970, "Bradykinin, Kallidin, and Kallikrein," Handbuch der Experimen- tellen Pharmakologie, Vol. 25, Berlin: Springer-Verlag.
  34. Goldblatt, H.J., R.F. Lynch, R.F. IIanzal, et al., 1934, "Studies on Experimental Hyper- tension. Production of Persistent Elevation of Systolic Blood Pressure by Means of Renal Ischemia," Journal of Experimental Medicine, 49, 347-379.
  35. Gavras et al., 1974, "An Angiotensin Converting Enzyme Inhibitor to Identify and Treat Vasoconstrictor and Volume Factors in Hypertensive Patients," N m England Journal of Medicine, 291, 817-821.
  36. Gilman, A.G., L.S. Goodman, T.W. Rail, and F. Murad, eds. 1985, Goodmanand Gilmarz's The Pharmacological Basis of Therapeutics, New York Macmillan.
  37. Gross, F., 1968, "The Regulation of Aldosterone Secretion by the Renin-Angiotensin System Under Various Conditions," Acta Endocrind. (Kbh.) (suppl. 124) 41-64.
  38. Hodge, R.L., R.D. Lowe, and J.R. Vane, 1967, "Concurrent Measurement of Renin and Angiotensin in the Circulation of the Dog," Nature, 215, 853.
  39. Julian, Desmond G., 1988, Cardiology, London: Bailliere Tindall.
  40. Laragh, J.H. et al., 1972, "Renin, Angiotensin and Aldosterone System in Pathogenesis and Management of Hypertensive Vascular Disease," American Journal of Medicine, -, 1984, "Concept of Anti-Renin System Therapy: Historic Perspective," American Journal of Medicine, 77(2A), 1-6.
  41. Mansfield, E., 1987, "Price Indices for R&D Inputs, 1969-1983," Management Science, 33. Ondetti, M.A., N.J. Williams, E.F. Sabo, J. Pluscec, E.R. Weaver, and 0. Kocy, 1971, "Angiotensin-Converting Enzyme Inhibitors from the Venom of Bothrops Jararca: Isolation, Elucidation of Structure and Synthesis," Biochemistry, v 10, 4033-4039.
  42. Ondetti, M.A., B. Rubin, and D.W. Cushman, 1977, "Design of Specific Inhibitors of 287, 1209-1214. 790-796. 296, 641-646. 52, 644-652.
  43. Angiotensin-Converting Enzyme. New Class of Orally Effective Antihypertensive Agents," Science, 196, 441-444.
  44. Pals et al., 1971, "A Specific Competitive Antagonist of the Vascular Action of Angioten- sin 11,'' Circulation Research, 29, 664.
  45. Patchett, A.A., E. Hams, E.W. Tristram, et al., 1980, "A New Class of Angiotensin- Converting Enzyme Inhibitors," h'uture, 288, 280-282.